-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to reports, there is a U-shaped association between serum potassium levels and short-term mortality in patients with hypertension
Recently, the heart blood vessels authoritative magazine published a research article on Hypertension, systolic blood pressure Intervention Trial (SPRINT) was a randomized controlled trial included 9361 over the age of 50 years old and without diabetes in high-risk patients, they were assigned to strengthen drop Pressure and standard pressure reduction group
Heart vascular diabetes
The researchers used Cox proportional hazards regression (including serum potassium as a time-related covariate) and restricted cubic splines to study the association between baseline and on-treatment serum potassium levels and death
The study obtained a total of 9336 individuals with baseline serum potassium levels, and 8473 individuals were measured at 12 months
It can be seen that the baseline and treatment serum potassium levels have nothing to do with death, and the effect of enhancing blood pressure is not affected by serum potassium levels
Serum potassium levels at baseline and during treatment have nothing to do with death, and the effect of enhancing blood pressure is not affected by serum potassium levels
Original source:
Christina Byrne.
